CORAL GABLES, Fla., April 21, 2011 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced that Steven R. Miller, Ph.D., Catalyst's Chief Operating Officer and Chief Scientific Officer, will be making a presentation on Friday, April 29, 2011 at 2:55pm ET at the Antiepileptic Drug Trials XI Conference, an in-depth, three day forum to be held April 27-29, 2011 at the Turnberry Isle Resort, Aventura (North Miami Beach), Florida. The conference will focus on issues related to antiepileptic drug (AED) development from preclinical discoveries through clinical evaluations. It will bring together representatives from academia, industry, the NIH, and the FDA to review what has been learned and to discuss strategies to enhance AED development.
